Evidence map›Paper›PMID 8298804›Full record

ArticleBritish journal of pharmacology1993

Effects of the novel potassium channel opener, UR-8225, on contractile responses in rat isolated smooth muscle.

F Perez-Vizcaino, O Casis, R Rodriguez, L A Gomez, J Garcia Rafanell, J Tamargo

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in British journal of pharmacology, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

F Perez-VizcainoDepartment of Pharmacology, School of Medicine, University Complutense of Madrid, Spain.
O Casis
R Rodriguez
L A Gomez
J Garcia Rafanell
J Tamargo
Universidad Complutense de Madrid · ESUriach (Spain) · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

1. The effects of UR-8225 [(1,2-dihydro-4-(1,2-dihydro-2-oxo-1-pyridyl)-2,2-dimethyl-1-oxonapht halen-6- carbonitrile)] and levcromakalim were studied on the electrical and contractile responses induced by noradrenaline and KCl and on 86Rb+ efflux in rat aortic rings and on spontaneous mechanical activity in rat portal vein segments. 2. UR-8225 and levcromakalim, 10(-9) M-10(-5) M, relaxed the contractile responses induced by noradrenaline (IC50 = 2.7 +/- 0.4 x 10(-6) M and 6.6 +/- 1.3 x 10(-7) M, respectively) or 30 mM KCl (IC50 = 1.4 +/- 0.2 x 10(-7) M and 9.4 +/- 1.3 x 10(-8) M, respectively) more effectively than those induced by 80 mM KCl. The relaxant effect on noradrenaline-induced contractions was independent of the presence or absence of functional endothelium. 3. The vasorelaxant effect of UR-8225 and levcromakalim can be competitively antagonized by glibenclamide, an ATP-sensitive K+ channel blocker. There were no differences in the calculated pA2 values for glibenclamide to inhibit UR-8225- and levcromakalim-induced relaxations (7.61 +/- 0.08 and 7.69 +/- 0.10, respectively). The slope of the Schild plot yielded values not significantly different from unity (0.95 +/- 0.06 and 0.96 +/- 0.05, respectively). 4. UR-8225 (10(-5) M) hyperpolarized the resting aortic membrane potential from -50.7 +/- 0.7 mV to -66.0 +/- 2.0 mV and stimulated 86Rb+ efflux. 5. UR-8225 and levcromakalim inhibited the contractions induced by Ca2+ in aortae incubated in Ca(2+)-free PSS containing methoxyverapamil in the presence of noradrenaline. 6. Both drugs inhibited the amplitude of spontaneous activity in portal veins (IC50 = 5.1 +/- 1.4 x 10-8 M and 1.5 +/- 0.7 x 10-8 M, respectively), this effect being competitively antagonized by glibenclamide.7. These results indicated that UR-8225 exhibited qualitatively similar, but slightly less potent,vasorelaxant effects than those exerted by levcromakalim, which suggests that they can be related to its ability to activate ATP-sensitive K+ channels in vascular smooth muscle cells.

Indexed as

AnimalsAntihypertensive AgentsBenzopyransCalciumCromakalimFemaleIn Vitro TechniquesIon Channel GatingMaleMembrane PotentialsMuscle ContractionMuscle, Smooth, VascularNaphthalenesNorepinephrinePortal VeinPotassium ChannelsAntihypertensive AgentsBenzopyransCalciumCromakalimNaphthalenesNorepinephrinePotassium ChannelsPotassium ChloridePyridonesPyrrolesRubidiumRubidium RadioisotopesUR 8225Vasodilator Agents

Identifiers

PMID8298804
PMCPMC2175824
OpenAlexW2050755479

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.